Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00526123 · ClinicalTrials.gov registry record · NA

Dialysis Catheter Comparative Clinical Trial

A NA study of End Stage Renal Disease, sponsored by Tyco Healthcare Group.

Completed
Registry status
NA
Development phase
599
Enrollment target
14
Study locations

NCT00526123: Completed NA study of End Stage Renal Disease, sponsored by Tyco Healthcare Group.

NCT00526123 is a NA study of End Stage Renal Disease that has completed, run by Tyco Healthcare Group. The registered enrollment target is 599 participants, below the 826-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (27% lower). The trial reports 14 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00526123, a NA study of End Stage Renal Disease, has completed, sponsored by Tyco Healthcare Group.

COMPLETED
Registry status
NA
Development phase
599 participants
Enrollment target
14
Study locations

Study Summary

The purpose of this clinical trial is to compare the longevity of two dialysis catheters.

Primary Outcome

% of participants that did not experience a catheter induced complication at the specified Outcome Measure Time Frame.

Conditions Studied

Interventions

  • DEVICE Symmetric Tip Catheter
  • DEVICE Conventional Split-tip Catheter

Study Locations (14)

North Carolina

  • Eastern Nephrology Associates - Greenville
  • Eastern Nephrology Associates - New Bern
  • Boice-Willis Clinic - Rocky Mount
  • Dialysis Access Group of Wake Forest University, LLC - Winston-Salem

Massachusetts

  • Tufts Medical Center - Boston
  • Massachusetts General Hospital - Boston

Pennsylvania

  • Temple University Hospital - Philadelphia
  • Nephrology Associates - Lankenau Hospital - Wynnewood

Alabama

  • Nephrology Associates, P.C. - Birmingham

Arizona

  • Southwest Kidney Institute - Phoenix

New York

  • SUNY Stony Brook Medical Center - Stony Brook

Ohio

  • Toledo Hospital - Toledo

South Carolina

  • Columbia Nephrology Associates - Columbia

Trial Details

FieldValue
Enrollment Target 599 participants
Start Date 2007-09
Est. Completion 2011-08
Phase NA
Tyco Healthcare Group

4 total trials

What the finished NCT00526123 record still lists

NCT00526123 is an interventional study that assigns participants to a tested intervention. The registered 599 participants enrollment target is mid-sized for trials with a published cap, below the 826-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (27% lower).

The record links to 1 condition, with End Stage Renal Disease appearing as the primary indexed condition, and to 2 interventions - of which Symmetric Tip Catheter is the first listed.

NCT00526123 lists 14 locations in 9 states (North Carolina, Massachusetts, Pennsylvania).

Frequently Asked Questions

What is clinical trial NCT00526123 about?

NCT00526123 is a clinical study titled "Dialysis Catheter Comparative Clinical Trial". The purpose of this clinical trial is to compare the longevity of two dialysis catheters.

What is the current status of trial NCT00526123?

This trial is currently completed. It is a NA study. The enrollment target is 599 participants. The study started on 2007-09. Estimated completion is 2011-08.

What conditions does trial NCT00526123 study?

This clinical trial studies the following conditions: End Stage Renal Disease.

What interventions are being tested in trial NCT00526123?

The interventions under investigation include: Symmetric Tip Catheter (DEVICE), Conventional Split-tip Catheter (DEVICE).

Who is sponsoring clinical trial NCT00526123?

This trial is sponsored by Tyco Healthcare Group, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00526123 being conducted?

This trial has 14 study locations across Alabama, Arizona, Massachusetts, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for End Stage Renal Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00526123's enrollment target sits among peer trials

599 10th of 86 higher than 77 of 86 other End Stage Renal Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other End Stage Renal Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06875973 · 599 participants · Phase 3

    Pelacarsen Roll-over Extension Program

  • NCT00004317 · 600 participants · Phase 4

    Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis

  • NCT00209235 · 600 participants · NA

    Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments

  • NCT01473784 · 600 participants · NA

    Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00526123, the US trial registry maintained by the National Library of Medicine. NCT00526123 (mid enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.